Sign In
Buy GLP
$48.63
+0.410 (+0.85%)
At Close: Jul 28, 2026
Functional Brands Inc. Announces Launch of GLP-Squared Injection
08:00am, Wednesday, 06'th May 2026
Proprietary Semaglutide + Tirzepatide Dual-Peptide Formulation Now Available Exclusively Through the Tru2u.health Platform Lake Oswego, Portland--(Newsfile Corp. - May 6, 2026) - Functional Brands Inc
Lilly's Oral GLP-1 Pill Foundayo Starts Strong in Oral Obesity Market
02:11pm, Tuesday, 05'th May 2026
Lilly's Foundayo is off to a strong start, drawing new prescribers and patients as broad pharmacy access and payer coverage fuel early oral obesity momentum.
Promino Responds to Growing Demand for Muscle Health Support as Health Canada Expands Access to Semaglutide
07:00am, Tuesday, 05'th May 2026
Rejuvenate Muscle Health™ Adds Prominent GLP-1 Support Call-Out to New Packaging Set to Debut Later This Month Across North America; ECRM "Best Drink 2025" Validation; Promino™ NSF Certified for S
Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%
04:50pm, Monday, 04'th May 2026
The hosts of Morning Brew Daily made a simple argument on a recent episode that the idea of the “Ozempic economy” should be replaced with the “Mounjaro economy” now that Eli Lilly is controlli
Novo Nordisk's Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance
02:04pm, Monday, 04'th May 2026
Novo Nordisk's Wegovy pill has created another boom in the GLP-1 drug market. Eli Lilly recently introduced its Foundayo pill for weight loss, three months after the launch of its rival's drug.
New York City, NY, May 04, 2026 (GLOBE NEWSWIRE) -- DISCLAIMER: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription medications t
Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent
01:05pm, Friday, 01'st May 2026
The $63-billion GLP-1 agonist industry is forecast to triple in the coming decade, so it's no surprise that pharmaceuticals companies of all sizes are scrambling to get in on the action. For the time
Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)
08:05am, Friday, 01'st May 2026
The addition of Ozempic® pill will give Weight Watchers Med+ members a new FDA-approved oral GLP-1 option for adults living with type 2 diabetes The addition of Ozempic® pill will give Weight Watche
Harris Teeter Offers GLP-1 Medications, Nutrition Support and Cost-Saving Options
07:00am, Friday, 01'st May 2026
Harris Teeter supports customers navigate weight management more affordably and comfortably with nutrition support, pharmacy expertise and fresh, quality foods. MATTHEWS, N.C.
New Strong Buy Stocks for May 1st
05:55am, Friday, 01'st May 2026
GLP, STRA, FMX, SANM and SSRM have been added to the Zacks Rank #1 (Strong Buy) List on May 1, 2026.
Best Income Stocks to Buy for May 1st
05:20am, Friday, 01'st May 2026
STRA, GLP and FMX made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 1, 2026.
Best Value Stocks to Buy for May 1st
05:11am, Friday, 01'st May 2026
STRA, GLP and ENVA made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 1, 2026.
Eli Lilly crushes Q1 estimates, raises full-year outlook as GLP-1 sales surge
11:43am, Thursday, 30'th Apr 2026
Eli Lilly and Co (NYSE:LLY) reported stronger-than-expected first-quarter 2026 results on April 30, driven by surging demand for its diabetes and obesity treatments Mounjaro and Zepbound. Shares rose
Eli Lilly CEO on new GLP-1 pill: It's been out 20 days and we have over 20,000 patients
11:06am, Thursday, 30'th Apr 2026
More than 20,000 people have started taking Eli Lilly's GLP-1 pill Foundayo in its first few weeks on the market, Lilly CEO Dave Ricks told CNBC on Thursday.
Should Value Investors Buy Global Partners (GLP) Stock?
10:40am, Thursday, 30'th Apr 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
